Apolizumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Apolizumab, covering 2013-07-16 to 2013-07-16. Get the full timeline:
Most recent: Clinical Trial Update: Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]